This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02742/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02742/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02742/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02742/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02742/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02742
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB02742 n14:DB02742
dcterms:title
Kifunensine
adms:identifier
n6:DB02742 n7:KIF n9:3697 n10:46936476 n13:46505714
n3:synthesisReference
Paul Benjes, "Process for preparing kifunensine intermediate and kifunensine therefrom." U.S. Patent US20040063973, issued April 01, 2004.
n3:IUPAC-Name
n4:271B5405-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B540B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B540A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5407-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5408-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5409-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5403-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5401-363D-11E5-9242-09173F13E4C5 n4:271B5404-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5402-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5411-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5412-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B540C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B540D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B540F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B540E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5410-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
109944-15-2
n3:Bioavailability
n4:271B5417-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5419-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B541A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5416-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5415-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5418-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5406-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5413-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5414-363D-11E5-9242-09173F13E4C5